Medical News
inicio
sindicaci;ón

Archive for April, 2007

Case Announces Launch Of Revolution Health Web Site

America Online co-founder Steve Case on Thursday in a webcast announced the launch of RevolutionHealth.com, a comprehensive health care information Web site for consumers sponsored by Revolution Health Group, which Case founded last year, Dow Jones reports (Gerencher, Dow Jones, 4/19). The no-cost Web site will include information on 1,500 medical conditions that users can sort by name or by treatment, as well as a directory of physicians that will include brief reviews written by patients. In addition, users will have the ability to develop their own pages on the Web site to store information and share the information with others. Users also will have the ability to maintain electronic health records on the Web site. Revolution Health in future plans to market on the Web site services such as resolution of disputes with health insurers (Kaiser Daily Health Policy Report, 4/16). Case also announced that Revolution Health has acquired CarePages, a no-cost Web site that allows caregivers to post information about the care they provide. Case said, “We created Revolution Health to make health and health care simpler for everyone, but particularly for busy moms, who often serve as the chief medical officers for their families”

Discovery Of An HIV Inhibitor In Human Blood Points To New Drug Class

Cheaper, Better Disease Treatments Expected From Faster Approach To Developing Antibodies

Opinion Pieces Address Issues Related To Medicare

Not All Beta-Adrenergic Receptors Cause Heart Disease Along The Same Pathway

Predicting Cancer Risk In The Long Term

Most attempts to create therapeutic cancer vaccines are based on custom-made approaches that use a patient’s own tumor cells to generate a strong immune response against cancer. However, developing these kinds of personalized vaccines is time-consuming, expensive and often impractical. Using an alternative approach, researchers at the University of Pittsburgh Cancer Institute (UPCI) in collaboration with the Gunma University School of Medicine in Japan, have developed a vaccine strategy for head and neck cancer that targets multiple peptides (parts of proteins) to activate the immune system to attack tumors. Their findings, abstract number 5113, were included in a press briefing on cancer vaccines at the annual meeting of the American Association for Cancer Research.

Head And Neck Cancer Vaccine Targets Proteins To Create Immune Response

Understanding Personal Genetic Risk For Familial Breast Cancer Eases Anxieties

Traditional Chinese Medicinal Herbs May Help Women With Breast Cancer

« Previous entries · Next entries »